PDL BioPharma Inc (NASDAQ:PDLI)

2.58
Delayed Data
As of Dec 04
 +0.04 / +1.57%
Today’s Change
1.86
Today|||52-Week Range
3.50
+5.37%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Operating ActivitiesNet Income / Starting Line332.8M63.7M110.7M-68.9M
 
 
 
 
 
Depreciation--12.0M24.7M15.8M
 
 
 
 
Total Other Cash Flow-57.8M51.4M-154.1M47.8M
 
 
 
 
 
Funds From Operations292.3M116.4M20.4M8.6M
 
 
 
 
 
Funds From/For Other Operating Expenses-9.2M14.7M-20.2M22.0M
 
 
 
 
 
Net Cash Flow - Operating Activities301.5M101.7M40.6M-13.4M
 
 
 
 
 
 
InvestingIncrease In Investments0.00-98.0M-23.2M0.00
 
 
 
Decrease In Investments1.9M4.7M115.0M4.1M
 
 
 
 
 
Capital Expenditures-9.0K-25.0K-1.3M-4.5M
 
 
 
 
 
Fixed Asset Disposal--250.0K0.000.00
 
 
Net Assets From Acquisitions 0.00-109.9M-2.2M0.00
 
 
 
Other Investing - Uses-35.2M-9.0M0.00-858.0K
 
 
 
 
Other Investing - Sources68.6M127.2M368.4M78.0M
 
 
 
 
 
Net Cash Flow Investing-79.6M-144.3M456.7M56.7M
 
 
 
 
 
 
FinancingShort Term Borrowings100.0M0.000.000.00
 
 
Long Term Borrowings0.00146.8M0.000.00
 
 
Long Term Debt Reduction-75.0M-25.0M0.00-126.4M
 
 
 
 
Net Proceeds Stock Sale0.000.000.000.00--
Common Preferred Redeemed-220.4M-120.0M-30.0M-49.1M
 
 
 
 
 
Common Dividends-98.3M-16.6M-222.0K-48.0K
 
 
 
 
 
Cash Dividends Paid - Total-98.3M-16.6M-222.0K-48.0K
 
 
 
 
 
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.0014.4M87.0M351.0K
 
 
 
 
Net Cash Flow - Financing-294.3M-29.2M-117.2M-176.0M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash-72.5M-71.7M380.1M-132.7M